HLA Stock Overview
Healthia Limited provides health services in Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Healthia Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$1.80 |
| 52 Week High | AU$1.80 |
| 52 Week Low | AU$0.85 |
| Beta | 1.08 |
| 1 Month Change | 0.84% |
| 3 Month Change | 3.01% |
| 1 Year Change | 52.12% |
| 3 Year Change | 39.15% |
| 5 Year Change | 74.27% |
| Change since IPO | 50.21% |
Recent News & Updates
Recent updates
Calculating The Fair Value Of Healthia Limited (ASX:HLA)
Jan 30
Healthia (ASX:HLA) Has Re-Affirmed Its Dividend Of AU$0.02
Mar 02Here's Why Healthia Limited's (ASX:HLA) CEO May Deserve A Raise
Nov 09Earnings Tell The Story For Healthia Limited (ASX:HLA) As Its Stock Soars 30%
Sep 17Healthia Limited (ASX:HLA) Stocks Shoot Up 30% But Its P/E Still Looks Reasonable
Sep 17Healthia (ASX:HLA) Is Increasing Its Dividend To AU$0.025
Sep 01I Ran A Stock Scan For Earnings Growth And Healthia (ASX:HLA) Passed With Ease
Aug 17Is Now An Opportune Moment To Examine Healthia Limited (ASX:HLA)?
May 19Is Healthia (ASX:HLA) A Risky Investment?
Apr 19With EPS Growth And More, Healthia (ASX:HLA) Is Interesting
Apr 03Announcing: Healthia (ASX:HLA) Stock Increased An Energizing 108% In The Last Year
Mar 19Insider Buying: The Healthia Limited (ASX:HLA) Independent Non-Executive Director Just Bought 4.7% More Shares
Mar 06What Kind Of Shareholders Hold The Majority In Healthia Limited's (ASX:HLA) Shares?
Feb 26Is There Now An Opportunity In Healthia Limited (ASX:HLA)?
Feb 09Healthia Limited's (ASX:HLA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 19Why Dividend Hunters Love Healthia Limited (ASX:HLA)
Dec 29Did You Miss Healthia's (ASX:HLA) 13% Share Price Gain?
Dec 10We're Not So Sure You Should Rely on Healthia's (ASX:HLA) Statutory Earnings
Nov 20
Shareholder Returns
| HLA | AU Healthcare | AU Market | |
|---|---|---|---|
| 7D | 0.3% | -4.4% | -2.7% |
| 1Y | 52.1% | -7.5% | 6.5% |
Return vs Industry: HLA exceeded the Australian Healthcare industry which returned -20.5% over the past year.
Return vs Market: HLA exceeded the Australian Market which returned 9.6% over the past year.
Price Volatility
| HLA volatility | |
|---|---|
| HLA Average Weekly Movement | 0.5% |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in AU Market | 16.8% |
| 10% least volatile stocks in AU Market | 3.1% |
Stable Share Price: HLA's share price has been volatile over the past 3 months.
Volatility Over Time: HLA's weekly volatility has decreased from 12% to 0% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | Wes Coote | www.healthia.com.au |
Healthia Limited provides health services in Australia. It operates through three segments: Feet & Ankles; Bodies & Minds; and Eyes & Ears. The company operates podiatry and retail footwear; physiotherapy, hand therapy, occupational therapy, exercise physiology, and speech pathology clinics; and optometry and audiology stores, as well as manufactures and sells orthotic devices.
Healthia Limited Fundamentals Summary
| HLA fundamental statistics | |
|---|---|
| Market cap | AU$252.06m |
| Earnings (TTM) | AU$5.47m |
| Revenue (TTM) | AU$252.56m |
46.1x
P/E Ratio1.0x
P/S RatioIs HLA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HLA income statement (TTM) | |
|---|---|
| Revenue | AU$252.56m |
| Cost of Revenue | AU$175.80m |
| Gross Profit | AU$76.75m |
| Other Expenses | AU$71.29m |
| Earnings | AU$5.47m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.039 |
| Gross Margin | 30.39% |
| Net Profit Margin | 2.16% |
| Debt/Equity Ratio | 50.7% |
How did HLA perform over the long term?
See historical performance and comparisonDividends
2.2%
Current Dividend Yield85%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/12/04 12:54 |
| End of Day Share Price | 2023/11/30 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2023/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Healthia Limited is covered by 4 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Russell Wright | Barclay Pearce Capital Pty Limited |
| Warren Jeffries | Canaccord Genuity |
| Wilson Wong | Jarden Limited |